Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement

Documenti analoghi

• Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit /Hyperactivity Disorder
  di: Shen Cheng, et al.
  Pubblicazione: (2024)
• Better Rejection‐Free Survival at Three Years in Kidney Transplant Recipients With Model‐Informed Precision Dosing of Mycophenolate Mofetil
  di: Claire Villeneuve, et al.
  Pubblicazione: (2024)
• Pharmacokinetics of Long‐Acting Ampicillin and Its Impact on the Gut Microbiome and Resistome in Rhesus Macaques ( Macaca mulatta )
  di: Annemiek Maaskant, et al.
  Pubblicazione: (2026)
• Off‐Label Use of Mycophenolate: Can Real‐World Evidence Fetch Regulatory Approval for Lupus Nephritis and Other Indications?
  di: Nisha Sharma, et al.
  Pubblicazione: (2024)
• Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
  di: Karen Rowland Yeo, et al.
  Pubblicazione: (2024)